Candice Hessel in Sugar Land, Texas

Home Texas Sugar Land

Candice Hessel has Nurse Practitioner as her primary medical specialty. Their primary office is: 16902 Southwest Fwy in Sugar Land, Texas. There is an additional office location, for a total of two, for Candice Hessel that can be viewed further down.

They're a part of the: Nluc Pllc medical group which has around 247 members. You can call their office at 832-342-9205 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2015 (around 9 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Candice Marie Hessel Office Phone and Directions

Candice Hessel
Nluc Pllc
16902 Southwest Fwy
Sugar Land, Texas 77479
832-342-9205

Patient Ratings
Please rate your experience with Candice Hessel below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 832-342-9205

Enter a starting address:

Healthcare Info for Candice Hessel

Medical School: Sorry, her university is not listed
Graduation Year: 2015
The Primary Medical Specialty for Candice Hessel is listed as: Nurse Practitioner
Approximate Years of Experience: 9
PAC (PECOS ID)#: 0042508798
NPI #: 1053781898
NPI Created On: 10/06/2015
NPI Last Updated Listed as: 06/13/2022
Primary Taxonomy Code: 363LF0000X
License Number:
869858
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 836010837

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Virology & Specialty Care

Name of Drug #1: Xofluza

Open Associated Drug #1: 50242-828-02